Organization · Venture Capital
TTM Capital
TTM Capital is a Shanghai-based investment firm established in 2020, focusing on early and growth-stage investments in the life sciences and healthcare sectors, particularly in biopharmaceuticals and medical devices.
Overview
What TTM Capital does
What TTM Capital is
TTM Capital is a Shanghai-based investment firm established in 2020, focusing on early and growth-stage investments in the life sciences and healthcare sectors, particularly in biopharmaceuticals and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find TTM Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
TTM Capital as a funder
Investment thesis
TTM Capital backs healthcare and life-science companies addressing unmet global medical needs through technology-driven innovation, focusing on selective opportunities in biopharmaceuticals, medical devices, and in vitro diagnostics.
Focus narrative
TTM Capital primarily invests in the biopharmaceutical sector, emphasizing areas such as oncology, immunology, and metabolic diseases. The firm seeks to create value through deep connections and collaborations within the healthcare ecosystem, focusing on segments where it has significant advantages.
Value beyond capital
TTM Capital adds value to its portfolio companies through deep connections and collaborations within the healthcare ecosystem, facilitating access to industry resources, expertise, and strategic partnerships that enhance growth and innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices · Digital Health
- Regions
- Global · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- XinThera
Portfolio context
Prost: Focuses on oncology and immunology, founded by Dr. Chen Shuhui, a former chief scientist at WuXi AppTec. ALLYRNA: Develops innovative small molecule drugs targeting high-value clinical needs, founded by Professor He Chuan. Lide Health: A hard-tech company commercializing scientific achievements from the Guangzhou National Laboratory. RayThera: An innovative drug company focusing on immunology and oncology, founded by Dr. Dong Qing. XinThera: Acquired by Gilead Sciences for $9.6 billion within two years of its founding. Weiling Medical: Developing medical-grade wireless brain-machine interface technology. Purui: Focuses on digital innovation in healthcare, incubated by IQVIA. NuoShen: Focused on innovative drug development for the central nervous system. Dina Yuan Sheng: Specializes in nucleic acid self-assembling drug carriers. Zeling Bio: Focuses on innovative drug research and industrialization. Anboning Life Science: Developing next-generation tumor immunotherapy. Xiaolu Bio: Founded by renowned immunologist Professor Liu Yongjun, focusing on innovative therapies for autoimmune and inflammatory diseases.
Common questions
What to know about TTM Capital
Upseed classifies TTM Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.